LACEY BLAKENEY: Open Payments
NPI 1326457151 · LAUREL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 20 payments from 12 companies in 2025. Trend: 2023 $380 · 2024 $627 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $83 |
| 180 Medical, Inc. | 3 | $77 |
| Teleflex LLC | 2 | $43 |
| Ferring Pharmaceuticals Inc. | 2 | $42 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $36 |
| Calyxo, Inc. | 1 | $28 |
| TELA Bio, Inc. | 1 | $27 |
| Dendreon Pharmaceuticals LLC | 1 | $24 |
| Integra LifeSciences Corporation | 1 | $22 |
| Stryker Corporation | 1 | $19 |
Products named: GEMTESA, BARRIGEL, ADSTILADRIN, GENTLECATH, GENTLECATH GLIDE, JOURNAVX, CVAC ASPIRATION SYSTEM, OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex).
Industry payments across MS — which companies pay providers there.
